Genpax
Connecting Pathogen Genomics
London, United Kingdom
38 employees
Seed
Total: $2.70M
Analytics, Biotechnology
General Information
London, United Kingdom
BounceWatch is an independent company data service, not affiliated with Genpax. To contact Genpax, visit genpax.co.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does Genpax compare?
A PDF of Genpax and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting Genpax soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
From the desk
Is Genpax on your competitive set?
Our desk can watch it and brief you on every move: hiring, funding, leadership, product and pricing.
Book a 7-day ReadoutDiscover More
United Kingdom Market
Analytics
About Genpax
Business keywords: genome sequencing, infectious disease, precision genomics, bacterial isolates, strain identification, outbreak management, transmission events, clinical significance, biotech, medtech, healthtech
Services & Products
Target Customers
Funding Rounds & Investors (1)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Seed Round | Fr.2.70M | - |
|
01 Mar 2022 |
Genpax Alternatives & Competitors
Cancer whole genome platform company
Multidimensional Health Intelligence Platform for digital twin and computational biology enabled car...
FAQ About Genpax
Source: BounceWatch company record for Genpax, https://bouncewatch.com/company/genpax, updated 25 February 2025. When citing, please name BounceWatch and link this page.
